Research Article

Evaluation of the Relationship Between Chronic Obstructive Pulmonary Diseases and Pulmonary Artery Diameter on Computed Tomography

Volume: 13 Number: 1 January 1, 2022
EN

Evaluation of the Relationship Between Chronic Obstructive Pulmonary Diseases and Pulmonary Artery Diameter on Computed Tomography

Abstract

Purpose: To study that how the non-asthma chronic obstructive pulmonary diseases (non-asthma-COPD) affect pulmonary artery diameters. Methods: The main pulmonary artery diameter (MPAD), right and left main pulmonary artery diameter (RPAD-LPAD), and the ratio of MPAD to ascending aorta diameter (AAD) (MPAD/AAD) in all subjects of the sample were assessed. Cases with non-asthma-COPD were classified as Group 1; those who were not was categorized into Group 2. The link between non-asthma-COPD and diameters of pulmonary artery and also the ratio of MPAD/AAD was evaluated statistically according to the groups. Results: In the study in which a total of 905 cases were evaluated, 138 in Group 1; 767 in Group 2. The patients' average age was 44.82 ± 16.53 (18-82). It was discovered that there is a statistically significant relationship between MPAD, RPAD and LPAD values and non-asthma-COPD, and it was higher in Group 1 (p=0.049, p=0.011, p=0.022; p<0,05, respectively). The MPAD/AAD value of the cases in Group 1 was discovered to be slightly higher than Group 2 (p=0.006; p<0,01). While the cut-off value for MPAD is ≥23.5 mm, the odds ratio was 1.573 (95% CI: 1.092-2.267); while the cut-off value for MPAD/AAD was ≥0.88, the odds ratio was 1.918 (95% CI: 1.253-2.938). According to ROC analysis, MPAD values were more specific for non-asthma-COPD than MPAD/AAD ratio, but MPAD/AAD ratio was more sensitive. Conclusion: Although there is a relationship between non-asthma-COPD and MPAD, RPAD, LPAD; the ratio of MPAD /AAD is more sensitive for the presence of non-asthma-COPD.

Keywords

References

  1. 1.Wright JL, Levy RD and Churg A. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment. Thorax. 2005;60:605-9. DOI: 10.1136/thx.2005.042994.
  2. 2. Chen X, Liu K, Wang Z, et al. Computed tomography measurement of pulmonary artery for diagnosis of COPD and its comorbidity pulmonary hypertension. Int J Chron Obstruct Pulmon Dis. 2015;10:2525-33. DOI: 10.2147/COPD.S94211.
  3. 3. Truong QA, Massaro JM, Rogers IS, et al. Reference values for normal pulmonary artery dimensions by noncontrast cardiac computed tomography: the Framingham Heart Study. Circ Cardiovasc Imaging. 2012;5:147-54. DOI:10.1161/CIRCIMAGING.111.968610
  4. 4. Barberà JA and Blanco I. Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management. Drugs. 2009;69(9):1153-71. DOI: 10.2165/00003495-200969090-00002.
  5. 5. Sakao S, Voelkel NF and Tatsumi K. The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations. Eur Respir Rev. 2014;23:350-5. DOI: 10.1183/09059180.00007913.
  6. 6. Shujaat A, Bajwa AA and Cury JD. Pulmonary Hypertension Secondary to COPD. Pulm Med. 2012;2012:203952. DOI: 10.1155/2012/203952.
  7. 7. Lynch DA, Austin JH, Hogg JC, et al. CT-Definable Subtypes of Chronic Obstructive Pulmonary Disease: A Statement of the Fleischner Society. Radiology. 2015;277:192-205. DOI: 10.1148/radiol.2015141579.
  8. 8. Matsuoka S, Yamashiro T, Washko GR, et al. Quantitative CT assessment of chronic obstructive pulmonary disease. Radiographics. 2010;30:55-66. DOI: 10.1148/rg.301095110.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Publication Date

January 1, 2022

Submission Date

May 1, 2021

Acceptance Date

November 8, 2021

Published in Issue

Year 2022 Volume: 13 Number: 1

EndNote
Tekcan Şanlı DE (January 1, 2022) Evaluation of the Relationship Between Chronic Obstructive Pulmonary Diseases and Pulmonary Artery Diameter on Computed Tomography. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 13 1 102–106.